Shorter eye treatment put to the test against standard crosslinking
Disease control
Completed
Researchers compare two versions of corneal crosslinking to treat progressive keratoconus or corneal ectasia, conditions where the cornea thins and bulges. Both use riboflavin eye drops and ultraviolet light, but one delivers the light faster and more intensely. The trial measure…
Phase 2/3 • Sponsor: Price Vision Group • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC